NFE2L2 and Parkinson disease: Similarly, in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) animal model of PD, the greater loss of dopamine transporter levels in the striatum of Nrf2 knockout mice than in wild-type at all MPTP doses tested was observed [145, 146].